CSL Plasma Inc. v. United States Customs and Border Protection, No. 21-5282 (D.C. Cir. 2022)Annotate this Case
Plaintiffs, a group of blood plasma companies, challenged a U.S. Customs and Border Protection ("CBP") rule precluding aliens from entering the U.S. using B-1 business visitor visas to sell plasma. Plaintiffs claimed that they invested substantial resources to develop plasma collection facilities near the border and that the CPB rule failed to take Plaintiffs' interests into account when creating the new rule.
The district court denied Plaintiffs' motion for a preliminary injunction, finding that the Plaintiffs' interests were not within the Administrative Procedure Act's "zone of interests." The district court, determining the zone-of-interest determination was jurisdictional, dismissed the complaint.
The D.C. Circuit reversed. For the Plaintiffs to sue under the APA, they must have been “adversely affected or aggrieved by agency action within the meaning of a relevant statute." However, the zone-of-interests determination is a merits issue, not a jurisdictional one. From there, the D.C. Circuit considered the merits, finding that the Plainitffs' case interests should have been considered under the B-1 analysis. Thus, the court remanded the case for further proceedings.